Back to Search Start Over

Assessment of beliefs and attitudes towards benzodiazepines using machine learning based on social media posts: an observational study

Authors :
Laura de Anta
Miguel Ángel Alvarez-Mon
Victor Pereira-Sanchez
Carolina C. Donat-Vargas
Francisco J. Lara-Abelenda
María Arrieta
María Montero-Torres
Cielo García-Montero
Óscar Fraile-Martínez
Fernando Mora
Miguel Ángel Ortega
Melchor Alvarez-Mon
Javier Quintero
Source :
BMC Psychiatry, Vol 24, Iss 1, Pp 1-12 (2024)
Publication Year :
2024
Publisher :
BMC, 2024.

Abstract

Abstract Background Benzodiazepines are frequently prescribed drugs; however, their prolonged use can lead to tolerance, dependence, and other adverse effects. Despite these risks, long-term use remains common, presenting a public health concern. This study aims to explore the beliefs and opinions held by the public regarding benzodiazepines, as understanding these perspectives may provide insights into their usage patterns. Methods We collected public tweets published in English between January 1, 2019, and October 31, 2020, that mentioned benzodiazepines. The content of each tweet and the characteristics of the users were analyzed using a mixed-method approach, including manual analysis and semi-supervised machine learning. Results Over half of the Twitter users highlighted the efficacy of benzodiazepines, with minimal discussion of their side effects. The most active participants in these conversations were patients and their families, with health professionals and institutions being notably absent. Additionally, the drugs most frequently mentioned corresponded with those most commonly prescribed by healthcare professionals. Conclusions Social media platforms offer valuable insights into users’ experiences and opinions regarding medications. Notably, the sentiment towards benzodiazepines is predominantly positive, with users viewing them as effective while rarely mentioning side effects. This analysis underscores the need to educate physicians, patients, and their families about the potential risks associated with benzodiazepine use and to promote clinical guidelines that support the proper management of these medications. Clinical trial number Not applicable.

Details

Language :
English
ISSN :
1471244X
Volume :
24
Issue :
1
Database :
Directory of Open Access Journals
Journal :
BMC Psychiatry
Publication Type :
Academic Journal
Accession number :
edsdoj.926999c1137740d38baf835178eb774b
Document Type :
article
Full Text :
https://doi.org/10.1186/s12888-024-06111-5